AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimith-MF 0.5 SR Tablet

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimith-MF 0.5 SR Tablet

Metformin-glimepiride 0.5mg extended-release tablets are antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. These tablets help regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Knowing these signs and having readily available glucose (e.g., sugary snacks or juice) is essential for management. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.

Uses of Glimith-MF 0.5 SR Tablet

Managing type 2 diabetes

Major Benefits of Glimith-MF 0.5 SR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimith-MF 0.5 SR Tablet whole; avoid chewing, crushing, or breaking it. Take this medication with food.

Common Side effects of Glimith-MF 0.5 SR Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimith-MF 0.5 SR Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimith-MF 0.5 SR Tablets should be taken with meals.

How Glimith-MF 0.5 SR Tablet works:

Glimepiride/Metformin 0.5mg sustained-release tablets (Glimith-MF 0.5 SR) combine two diabetes medications. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimith-MF 0.5 SR Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimith-MF 0.5 SR Tablet during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimith-MF 0.5 SR Tablet are incompatible. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimith-MF 0.5 SR Tablet cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimith-MF 0.5 SR Tablet is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimith-MF 0.5 SR Tablets cautiously, potentially requiring dosage modification. Consult your physician. For individuals with mild to moderate hepatic dysfunction, initiation with a low Glimith-MF 0.5 SR Tablet dose is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimith-MF 0.5 SR Tablet :

Should you forget to take a Glimith-MF 0.5 SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimith-MF 0.5 SR Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimith-MF 0.5 SR Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimith-MF 0.5 SR Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimith-MF 0.5 SR Tablets and seek immediate medical attention.
Glimith-MF 0.5 SR Tablet combines glimepiride and metformin to treat type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimith-MF 0.5 SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimith-MF 0.5 SR Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimith-MF 0.5 SR Tablet can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimith-MF 0.5 SR Tablets and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimith-MF 0.5 SR Tablet
35
MRP 40
12% off